Research priorities for autosomal dominant polycystic kidney disease: a UK priority setting partnership

Tess Harris1, Hannah R Bridges2, Wendy D Brown3

  • 1Polycystic Kidney Disease Charity, London, UK tess.harris@pkdcharity.org.uk.

BMJ Open
|June 15, 2022
PubMed

Insights

Autosomal dominant polycystic kidney disease (ADPKD) research priorities were identified by patients, carers, and healthcare professionals. Top concerns include slowing disease progression and improving early treatment and care organization for better outcomes.

Area of Science:

  • Nephrology
  • Genetics
  • Public Health

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder, causing 7-10% of kidney failure cases.
  • Current research on ADPKD is extensive, but funding allocation lacks clear priorities.
  • A priority setting partnership was established to identify and rank key research uncertainties in ADPKD care.

Purpose of the Study:

  • To identify and prioritize research questions in Autosomal dominant polycystic kidney disease (ADPKD) care.
  • To involve patients, carers, and healthcare professionals in setting research priorities.
  • To guide future research funding for ADPKD to maximize improvements in patient outcomes.

Main Methods:

  • Adapted James Lind Alliance (JLA) methodology was employed.
  • Uncertainties in ADPKD care were identified from literature and refined into indicative questions.
  • A survey and online consensus workshop involving patients, carers, and healthcare professionals established the top 10 research priorities.

Main Results:

  • 117 uncertainties were refined into 35 indicative questions, with 17 shortlisted via survey.
  • The top 10 research questions were agreed upon by workshop participants.
  • Key priorities focused on slowing ADPKD progression, identifying candidates for early treatment, and optimizing care organization.

Conclusions:

  • The identified priorities reflect the multifaceted challenges of living with and treating ADPKD.
  • Future ADPKD research funding should align with these patient- and clinician-identified priorities.
  • Focusing on these key areas can maximize improvements in ADPKD outcomes.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.4K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
81